Jana Care, a Watertown, MA-based developer of at-home self-administered testing technologies for chronic kidney and heart disease management, raised an initial closing of $6M funding round.
The round was led by IAG Capital Partners with participation from Agent Capital, First Avenue Ventures, Minocherhomjee Family Trust and existing investors Patamar Capital, Team Fund LP, MK Energy Corporation. In conjunction with the funding, Dr. Ehsan Jabbarzadeh, Venture Partner, IAG Capital Partners, joined Jana’s Board of Directors.
The company intends to use the funds to expand the development of its quantitative blood testing platform.
Led by CEO Anh Hoang-Lindsay, Jana Care is a medical technology company that develops point-of-care testing platforms for the screening and management of chronic diseases – heart failure, chronic kidney disease and diabetes. Its novel digitally connected platform enables real-time testing using fingerstick blood samples at-home, with new tests for NT-proBNP, potassium and serum creatinine in development-biomarkers that are critical for managing kidney and heart disease patients.
Jana Care has established a product development and production facility in Bangalore, India.
FinSMEs
09/11/2023